T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$1.68B |
| 2 |
Eli Lilly
LLY
|
+$1.43B |
| 3 |
Bank of America
BAC
|
+$1.17B |
| 4 |
Tesla
TSLA
|
+$1.13B |
| 5 |
Wells Fargo
WFC
|
+$734M |
Top Sells
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$20.6B |
| 2 |
Microsoft
MSFT
|
+$5.74B |
| 3 |
Amazon
AMZN
|
+$3.33B |
| 4 |
Yum! Brands
YUM
|
+$2.6B |
| 5 |
Salesforce
CRM
|
+$2.35B |
Sector Composition
| 1 | Technology | 26.11% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Alkermes
ALKS
$4.45B
| $105M | 0.02% |
4,687,171
-5,752,767
| -55% | -$128M |
|
477
Dover
DOV
$24.1B
| $105M | 0.02% |
896,881
+263,414
| +42% | +$30.7M |
|
478
Arthur J. Gallagher & Co
AJG
$75.2B
| $104M | 0.02% |
607,091
-208,629
| -26% | -$35.7M |
|
479
Martin Marietta Materials
MLM
$37.2B
| $103M | 0.02% |
321,212
-1,742,252
| -84% | -$561M |
|
480
Opendoor
OPEN
$4.31B
| $103M | 0.02% |
33,251,398
-19,241,752
| -37% | -$59.8M |
|
481
EastGroup Properties
EGP
$8.72B
| $103M | 0.02% |
716,244
-2,248,340
| -76% | -$325M |
|
482
Lazard
LAZ
$5.25B
| $103M | 0.02% |
3,233,804
-517,049
| -14% | -$16.5M |
|
483
Main Street Capital
MAIN
$5.97B
| $102M | 0.02% |
3,043,877
+542,503
| +22% | +$18.2M |
|
484
Relay Therapeutics
RLAY
$700M
| $102M | 0.02% |
4,561,363
-738,944
| -14% | -$16.5M |
|
485
Gilead Sciences
GILD
$143B
| $102M | 0.02% |
1,653,054
-404,237
| -20% | -$24.9M |
|
486
MACOM Technology Solutions
MTSI
$9.81B
| $102M | 0.02% |
1,961,661
+1,942,084
| +9,920% | +$101M |
|
487
Imperial Oil
IMO
$46.6B
| $101M | 0.02% |
2,343,886
-2,233,558
| -49% | -$96.6M |
|
488
McCormick & Company Non-Voting
MKC
$18.4B
| $101M | 0.02% |
1,420,441
+2,607
| +0.2% | +$186K |
|
489
Enphase Energy
ENPH
$4.85B
| $99.2M | 0.02% |
357,638
-4,546
| -1% | -$1.26M |
|
490
Grupo Aeroportuario del Sureste
ASR
$10.1B
| $99.2M | 0.02% |
505,575
-22,069
| -4% | -$4.33M |
|
491
Pinterest
PINS
$24B
| $99M | 0.02% |
4,248,117
-10,901,240
| -72% | -$254M |
|
492
Paychex
PAYX
$47.9B
| $98.3M | 0.02% |
875,985
-963,331
| -52% | -$108M |
|
493
Intellia Therapeutics
NTLA
$1.21B
| $97.2M | 0.02% |
1,737,260
-310,071
| -15% | -$17.4M |
|
494
Voya Financial
VOYA
$7.3B
| $97.1M | 0.02% |
1,605,403
-965,701
| -38% | -$58.4M |
|
495
Arvinas
ARVN
$575M
| $97M | 0.02% |
2,179,768
-1,087,802
| -33% | -$48.4M |
|
496
KT
KT
$9.52B
| $96M | 0.02% |
7,854,781
+41,647
| +0.5% | +$509K |
|
497
Valero Energy
VLO
$49.2B
| $94.8M | 0.02% |
887,578
-455,720
| -34% | -$48.7M |
|
|
NIMC
498
DELISTED
NiSource Inc. Series A Corporate Units
NIMC
| – | – |
-967,385
| Closed | -$110M |
|
499
Royalty Pharma
RPRX
$15.6B
| $94.1M | 0.02% |
2,342,810
-9,732
| -0.4% | -$391K |
|
500
TransDigm Group
TDG
$72.5B
| $92.6M | 0.02% |
176,479
+1,407
| +0.8% | +$738K |
|